Empowering mental health professionals with peer-reviewed psychiatric research and insights
Page 4
More JCP Articles
Consensus Statement
Next-Step Treatment Options for Treatment-Resistant Depression
January 21, 2026
Strong consensus emerged for augmentation with second-generation antipsychotics, TMS, and ketamine/esketamine in the base vignette. Preferences shifted to include non-augmentative antidepressants and ECT based on patient characteristics.
Original Research
Geographic Differences in Cannabis Use and Cannabis Use Disorder in the US Veteran Population
January 19, 2026
Significant regional differences were observed in cannabis use and cannabis use disorder (CUD). Veterans in the Pacific region had the highest rates of cannabis use and CUD.
Original Research
Innovation in Psychiatric Drug Development: A Quantitative Analysis of FDA-Approved Psychiatric Drugs, 2012–2024
January 12, 2026
Innovation in psychiatric drug development in the past 13 years was limited, with most new drugs representing incremental advances rather than groundbreaking innovations.
Clinical and Practical Psychopharmacology
Pregabalin in Pregnancy: Major Congenital Malformations, Other Birth Outcomes, and Neurodevelopmental Outcomes
January 7, 2026
About 0.04%-0.14% of women may use pregabalin during pregnancy. This article examines outcomes of pregnancies that were exposed to gabapentin.
Brief Report
Exercise Reduces Dysphoria in Clinical High-Risk for Psychosis: A Randomized Controlled Trial
January 7, 2026
Dysphoric mood was significantly reduced after an exercise intervention that included included high-impact treadmill interval training; there were no significant changes in other general symptoms.
